A Clinical Study of TK216 in Patients With Relapsed or Refractory Ewing's Sarcoma
Clinical trial NCT05046314 · COMPLETED
Trial details
- NCT number
- NCT05046314
- Sponsor
- Shanghai Pharmaceuticals Holding Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-12
- Primary completion
- 2025-02-05
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.